Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
Cancers · 23.05.2024 · 16 (11) · 1981
DOI: 10.3390/cancers16111981 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.05.2024. Verfasst von Mariia Ivanova und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, European Institute of Oncology IRCCS, 20141 Milan, Italy. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, NextGenerationEU, Giulia d’Amati.
Abstract (Originalsprache)
Effective risk assessment in early breast cancer is essential for informed clinical decision-making, yet consensus on defining risk categories remains challenging. This paper explores evolving approaches in risk stratification, encompassing histopathological, immunohistochemical, and molecular biomarkers alongside cutting-edge artificial intelligence (AI) techniques. Leveraging machine learning, deep learning, and convolutional neural networks, AI is reshaping predictive algorithms for recurrence risk, thereby revolutionizing diagnostic accuracy and treatment planning. Beyond detection, AI applications extend to histological subtyping, grading, lymph node assessment, and molecular feature identification, fostering personalized therapy decisions. With rising cancer rates, it is crucial to implement AI to accelerate breakthroughs in clinical practice, benefiting both patients and healthcare providers. However, it is important to recognize that while AI offers powerful automation and analysis tools, it lacks the nuanced understanding, clinical context, and ethical considerations inherent to human pathologists in patient care. Hence, the successful integration of AI into clinical practice demands collaborative efforts between medical experts and computational pathologists to optimize patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pathology, European Institute of Oncology IRCCS, 20141 Milan, Italy.
- Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, 20141 Milan, Italy.
- Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
- Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy.
- Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
ORCID-Profile: Mariia Ivanova, Carlo Pescia, Eltjona Mane, Elham Sajjadi, Cristian Scatena, Giulia d'Amati, Francesca Maria Porta, Carmen Criscitiello, Giuseppe Curigliano, Nicola Fusco
Förderung
- Italian Ministry of Health
- NextGenerationEU
- Giulia d’Amati
Zitieren
APA
Ivanova, M., Pescia, C., Trapani, D., Venetis, K., Frascarelli, C., Mane, E., Cursano, G., Sajjadi, E., Scatena, C., Cerbelli, B., d'Amati, G., Porta, F. M., Guerini-Rocco, E., Criscitiello, C., Curigliano, G., & Fusco, N. (2024). Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence. Cancers, 16(11), 1981. https://doi.org/10.3390/cancers16111981
Vancouver
Ivanova M, Pescia C, Trapani D, Venetis K, Frascarelli C, Mane E, et al. Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence. Cancers. 2024;16(11):1981. doi:10.3390/cancers16111981
BibTeX
@article{Ivanova2024,
author = {Ivanova, Mariia and Pescia, Carlo and Trapani, Dario and Venetis, Konstantinos and Frascarelli, Chiara and Mane, Eltjona and Cursano, Giulia and Sajjadi, Elham and Scatena, Cristian and Cerbelli, Bruna and d'Amati, Giulia and Porta, Francesca Maria and Guerini-Rocco, Elena and Criscitiello, Carmen and Curigliano, Giuseppe and Fusco, Nicola},
title = {Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence},
journal = {Cancers},
year = {2024},
volume = {16},
number = {11},
pages = {1981},
doi = {10.3390/cancers16111981}
}
EUVIMED